Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

402
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

180
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

INTRAVESICAL BACILLUS CALMETTE-GUERIN FOR TREATMENT OF REFRACTORY INTERSTITIAL CYSTITIS

Pages

  18-23

Abstract

 Introduction: The aim of this study was to examine the efficacy and safety of intravesical BACILLUS CALMETTE-GUERIN (BCG) in the TREATMENT of refractory INTERSTITIAL CYSTITIS (IC).Materials and Methods:  Thirteen patients with refractory IC were enrolled in the study. They were scheduled to receive 6 weekly courses of TREATMENT with intravesical BCG. Variables including the frequency, nocturia, urgency, pelvic pain, dyspareunia, dysuria, IC symptom index, IC problem index, and average voided volume were assessed every 6 months after the BCG therapy. Results: Thirteen patients received the complete course of intravesical BCG therapy. Twenty-four months after the TREATMENT a mean improvement of 51.9% was seen in frequency (P = 0.001), 43.2% in nocturia (P = 0.002), 28.7% in urgency (P = 0.004), 43.1% in pelvic pain (P = 0.001), 58.3% in dyspareunia (P = 0.003), 6.5% in dysuria (P = 0.16), 57.7% in the O’Leary-Sant IC symptom index (P = 0.001), and 61.8% in the O’Leary-Sant IC problem index (P = 0.001) scores. A significant improvement was seen in the mean average voided volume at the 24th follow-up month (89.5%; P = 0.001).Conclusion: Intravesical BCG is a relatively effective TREATMENT in patients with refractory IC. Its efficacy seems to be modest and lasts for at least 24 months in majority of the patients. It is also safe and well tolerated.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    AGHAMIR, S.M.K., MOHSENI, M.GH., & ARASTEH, S.. (2007). INTRAVESICAL BACILLUS CALMETTE-GUERIN FOR TREATMENT OF REFRACTORY INTERSTITIAL CYSTITIS. UROLOGY JOURNAL, 4(1), 18-23. SID. https://sid.ir/paper/270749/en

    Vancouver: Copy

    AGHAMIR S.M.K., MOHSENI M.GH., ARASTEH S.. INTRAVESICAL BACILLUS CALMETTE-GUERIN FOR TREATMENT OF REFRACTORY INTERSTITIAL CYSTITIS. UROLOGY JOURNAL[Internet]. 2007;4(1):18-23. Available from: https://sid.ir/paper/270749/en

    IEEE: Copy

    S.M.K. AGHAMIR, M.GH. MOHSENI, and S. ARASTEH, “INTRAVESICAL BACILLUS CALMETTE-GUERIN FOR TREATMENT OF REFRACTORY INTERSTITIAL CYSTITIS,” UROLOGY JOURNAL, vol. 4, no. 1, pp. 18–23, 2007, [Online]. Available: https://sid.ir/paper/270749/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top